annual EBITDA:
-$202.12M-$45.35M(-28.93%)Summary
- As of today (August 15, 2025), AUTL annual EBITDA is -$202.12 million, with the most recent change of -$45.35 million (-28.93%) on December 31, 2024.
- During the last 3 years, AUTL annual EBITDA has fallen by -$69.65 million (-52.58%).
- AUTL annual EBITDA is now -1354.34% below its all-time high of -$13.90 million, reached on September 30, 2016.
Performance
AUTL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$59.55M+$3.41M(+5.42%)Summary
- As of today (August 15, 2025), AUTL quarterly EBITDA is -$59.55 million, with the most recent change of +$3.41 million (+5.42%) on June 1, 2025.
- Over the past year, AUTL quarterly EBITDA has dropped by -$2.93 million (-5.17%).
- AUTL quarterly EBITDA is now -108.32% below its all-time high of -$28.58 million, reached on December 31, 2022.
Performance
AUTL quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$261.32M-$2.93M(-1.13%)Summary
- As of today (August 15, 2025), AUTL TTM EBITDA is -$261.32 million, with the most recent change of -$2.93 million (-1.13%) on June 1, 2025.
- Over the past year, AUTL TTM EBITDA has dropped by -$87.50 million (-50.34%).
- AUTL TTM EBITDA is now -757.30% below its all-time high of -$30.48 million, reached on March 31, 2019.
Performance
AUTL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AUTL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.9% | -5.2% | -50.3% |
| 3 y3 years | -52.6% | -33.6% | -57.3% |
| 5 y5 years | -50.4% | -54.4% | -74.1% |
AUTL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -52.9% | at low | -108.3% | +18.6% | -78.9% | at low |
| 5 y | 5-year | -52.9% | at low | -108.3% | +18.6% | -78.9% | at low |
| alltime | all time | -1354.3% | at low | -108.3% | +18.6% | -757.3% | at low |
AUTL EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$59.55M(-5.4%) | -$261.32M(+1.1%) |
| Mar 2025 | - | -$62.96M(-13.9%) | -$258.40M(+11.2%) |
| Dec 2024 | -$202.12M(+28.9%) | -$73.10M(+11.2%) | -$232.39M(+17.1%) |
| Sep 2024 | - | -$65.72M(+16.1%) | -$198.40M(+14.1%) |
| Jun 2024 | - | -$56.62M(+53.2%) | -$173.83M(+8.6%) |
| Mar 2024 | - | -$36.95M(-5.5%) | -$160.05M(+2.2%) |
| Dec 2023 | -$156.77M(+18.5%) | -$39.11M(-4.9%) | -$156.58M(+7.2%) |
| Sep 2023 | - | -$41.14M(-4.0%) | -$146.05M(-0.4%) |
| Jun 2023 | - | -$42.84M(+28.0%) | -$146.61M(-1.2%) |
| Mar 2023 | - | -$33.48M(+17.1%) | -$148.33M(-4.1%) |
| Dec 2022 | -$132.24M(-0.2%) | -$28.58M(-31.5%) | -$154.74M(-8.8%) |
| Sep 2022 | - | -$41.71M(-6.4%) | -$169.68M(+2.1%) |
| Jun 2022 | - | -$44.56M(+11.7%) | -$166.11M(+4.7%) |
| Mar 2022 | - | -$39.88M(-8.4%) | -$158.68M(+1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$132.47M(-17.5%) | -$43.52M(+14.1%) | -$156.60M(-1.6%) |
| Sep 2021 | - | -$38.14M(+2.7%) | -$159.15M(-2.3%) |
| Jun 2021 | - | -$37.12M(-1.8%) | -$162.92M(-0.9%) |
| Mar 2021 | - | -$37.81M(-17.9%) | -$164.37M(+0.1%) |
| Dec 2020 | -$160.60M(+19.5%) | -$46.07M(+9.9%) | -$164.20M(+5.2%) |
| Sep 2020 | - | -$41.92M(+8.7%) | -$156.13M(+4.0%) |
| Jun 2020 | - | -$38.57M(+2.5%) | -$150.13M(+1.1%) |
| Mar 2020 | - | -$37.64M(-0.9%) | -$148.56M(+5.1%) |
| Dec 2019 | -$134.40M(+140.8%) | -$38.00M(+5.8%) | -$141.40M(+36.8%) |
| Sep 2019 | - | -$35.91M(-2.9%) | -$103.40M(+53.2%) |
| Jun 2019 | - | -$37.00M(+21.4%) | -$67.48M(+121.4%) |
| Mar 2019 | - | -$30.48M | -$30.48M |
| Sep 2018 | -$55.82M(+149.1%) | - | - |
| Sep 2017 | -$22.41M(+61.2%) | - | - |
| Sep 2016 | -$13.90M | - | - |
FAQ
- What is Autolus Therapeutics plc annual EBITDA?
- What is the all time high annual EBITDA for Autolus Therapeutics plc?
- What is Autolus Therapeutics plc annual EBITDA year-on-year change?
- What is Autolus Therapeutics plc quarterly EBITDA?
- What is the all time high quarterly EBITDA for Autolus Therapeutics plc?
- What is Autolus Therapeutics plc quarterly EBITDA year-on-year change?
- What is Autolus Therapeutics plc TTM EBITDA?
- What is the all time high TTM EBITDA for Autolus Therapeutics plc?
- What is Autolus Therapeutics plc TTM EBITDA year-on-year change?
What is Autolus Therapeutics plc annual EBITDA?
The current annual EBITDA of AUTL is -$202.12M
What is the all time high annual EBITDA for Autolus Therapeutics plc?
Autolus Therapeutics plc all-time high annual EBITDA is -$13.90M
What is Autolus Therapeutics plc annual EBITDA year-on-year change?
Over the past year, AUTL annual EBITDA has changed by -$45.35M (-28.93%)
What is Autolus Therapeutics plc quarterly EBITDA?
The current quarterly EBITDA of AUTL is -$59.55M
What is the all time high quarterly EBITDA for Autolus Therapeutics plc?
Autolus Therapeutics plc all-time high quarterly EBITDA is -$28.58M
What is Autolus Therapeutics plc quarterly EBITDA year-on-year change?
Over the past year, AUTL quarterly EBITDA has changed by -$2.93M (-5.17%)
What is Autolus Therapeutics plc TTM EBITDA?
The current TTM EBITDA of AUTL is -$261.32M
What is the all time high TTM EBITDA for Autolus Therapeutics plc?
Autolus Therapeutics plc all-time high TTM EBITDA is -$30.48M
What is Autolus Therapeutics plc TTM EBITDA year-on-year change?
Over the past year, AUTL TTM EBITDA has changed by -$87.50M (-50.34%)